HIV Alert: Managing HIV/HCV Coinfection

Listen to downloadable audio from a series of live Webinars by Annie Luetkemeyer, MD, and Mark S. Sulkowski, MD, in which they provide expert insight and address audience questions on managing HIV in the setting of HCV coinfection.
Format: Audio (.mp3)
File Size: 10.06 MB
Released: December 12, 2017

Listen to downloadable audio from a series of live Webinars by Annie Luetkemeyer, MD, and Mark S. Sulkowski, MD, in which they provide expert insight and address audience questions on managing HIV in the setting of HCV coinfection. (50 minutes)

Annie Luetkemeyer, MD, has disclosed that she has received funds for research support (paid to her institution) from AbbVie, Gilead Sciences, Merck, Proteus, and ViiV.

Mark S. Sulkowski, MD, has disclosed that he has received consulting fees from AbbVie, Cocrystal, Gilead Sciences, Janssen, Merck, and Trek and funds for research support (paid to Johns Hopkins University) from AbbVie, Gilead Sciences, Janssen, and Merck.

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

Downloadable slideset from Clinical Care Options on HIV PrEP pharmacy services, with insights from Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP

Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP Released: January 4, 2019

Clinical Care Options’ expert audio analysis of the latest data and guideline recommendations for initial ART, provided by Daniel R. Kuritzkes, MD

Daniel R. Kuritzkes, MD Released: December 18, 2018

Find out what pharmacists can do to expand HIV PrEP uptake for those at high risk of HIV in this interactive CPE module from Clinical Care Options

John Faragon, PharmD, BCPS, AAHIVP
Program Director
Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Pharmacists: 1.0 contact hour (0.1 CEUs) Released: December 14, 2018 Expiration: December 13, 2019

Focused commentary from Daniel R. Kuritzkes, MD, on the latest reports from fall 2018 HIV conferences on antiretroviral drug safety during pregnancy.

Daniel R. Kuritzkes, MD Released: December 13, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?